How MSO Structure Affects Your Healthcare Transaction
If you’re a physician group owner or healthcare platform operator thinking about a sale, you’ve probably heard that Management Services Organization (MSO) structure matters to buyers. That’s true — but the reasons are more nuanced than most content on this topic suggests, and the implications for your transaction depend heavily on how your MSO is built, documented, and operating in practice.
At The Bloom Organization, we advise healthcare practice owners through sell-side M&A transactions. MSO structure comes up in virtually every engagement we run, whether the client has a fully developed MSO in place or is considering whether to establish one ahead of going to market. Here’s what we see buyers actually focus on — and what practice owners should understand before entering a process.
What an MSO Is (and Isn’t) in the Context of a Transaction
An MSO is a separate entity that provides non-clinical administrative services — billing, credentialing, HR, IT, compliance, payer contracting — to one or more healthcare practices. The clinical entity retains control over medical decision-making, and the MSO handles the business operations under a management services agreement (MSA).
This structure exists in large part because of corporate practice of medicine (CPOM) restrictions. Most states prohibit non-physician entities from employing physicians or directly controlling clinical operations. The MSO/practice entity split is the standard workaround — and it’s how most private equity-backed healthcare platforms are organized.
For practice owners, the important thing to understand is that buyers aren’t just acquiring your practice. In a typical PE-backed healthcare transaction, the buyer acquires or controls the MSO, and the clinical entity enters into a long-term MSA with that MSO. The structure of that relationship — the MSA terms, the fee arrangement, the governance rights — directly shapes deal economics and how the purchase price is allocated.
Why Buyers Care About MSO Maturity
When a buyer evaluates a healthcare platform, the MSO isn’t a nice-to-have. It’s the operating infrastructure they’re underwriting. A well-functioning MSO signals that the business can integrate new acquisitions, support multi-site operations, and scale without proportional increases in overhead.
Buyers scrutinize the MSA closely. They want to see that the fee structure (whether it’s a fixed fee, percentage of collections, or cost-plus model) is defensible, market-rate, and sustainable. An MSA that extracts too much value from the clinical entity raises regulatory red flags. One that’s too thin limits the buyer’s ability to capture economics through the MSO.
Buyers distinguish between MSOs that exist on paper and MSOs that are genuinely operating centralized services. A practice that has an MSO entity on its org chart but still runs billing, credentialing, and HR independently at each site doesn’t get MSO-level credit in a buyer’s model. Buyers look for standardized revenue cycle management, unified financial reporting, and consistent operational workflows across locations.
Depending on your state, the line between permissible administrative support and impermissible corporate practice of medicine can be narrow. Buyers — and their counsel — will examine whether your MSO structure respects that line. Governance documents, clinical decision-making authority, and the practical reality of how the MSO and practice entity interact all get scrutinized.
One of the primary reasons PE buyers build through MSO platforms is speed of integration. If your MSO already has standardized onboarding processes, shared technology infrastructure, and templated MSAs, a buyer can model adding new acquisitions to your platform with lower integration cost and risk. That matters for how they value the business.
The MSO Question for Practices That Don’t Have One
Not every practice going to market has an MSO in place, and that’s not automatically a problem. Smaller physician groups often operate as a single entity without a separate management company. Buyers account for this — they’ll typically restructure the transaction to create an MSO/clinical entity split at closing.
That said, the absence of an MSO can affect your transaction in a few ways:
Operational diligence goes deeper. Without a centralized services platform, buyers need to assess whether the administrative functions currently embedded in your practice can be separated, standardized, and eventually scaled. If your billing is managed by one person who’s been there for 15 years and nothing is documented, that’s a risk factor.
Purchase price allocation gets more complex. The split between MSO and clinical entity value has real tax and structural implications. Practices that haven’t thought through this in advance may find themselves navigating it under time pressure during a transaction.
You may leave value on the table. A practice that has already built repeatable operational infrastructure — even if it’s not formally structured as an MSO — can present a stronger case to buyers. Documented workflows, clean financial reporting with normalized EBITDA, and technology systems that aren’t held together with workarounds all contribute to buyer confidence.
This doesn’t mean you need to rush out and form an MSO before going to market. But understanding how buyers will view your operational infrastructure — and addressing gaps early — is part of what proper transaction preparation looks like.
Physician Alignment Is the Real Diligence Battleground
Buyers can model revenue growth and cost synergies. What they can’t easily model is whether your physicians will stay, remain productive, and support the platform’s growth after closing.
In MSO-structured transactions, physician alignment shows up in concrete, diligence-able ways: employment agreements or professional services agreements with the clinical entity, non-compete and non-solicitation provisions, compensation structures (and whether they’re compliant with fair market value and Stark Law requirements), governance rights within the clinical entity, and the physicians’ historical willingness to operate within standardized protocols.
A practice where the founding physician controls everything, key associates have no contractual commitment, and there’s no governance structure beyond “everyone reports to Dr. Smith” presents real execution risk for a buyer. That risk gets priced into the deal — or it kills the deal entirely.
What This Means for Your Sale Process
MSO structure isn’t a checkbox exercise. It’s one of the central lenses through which buyers evaluate healthcare businesses, and it touches valuation, deal structure, tax treatment, regulatory risk, and integration planning.
Whether you have a mature MSO platform or a single-entity practice, the question isn’t whether structure matters — it’s whether you’ve done the work to understand how a buyer will view yours, and whether there are steps you should take before going to market.
About The Bloom Organization
The Bloom Organization is a sell-side M&A advisory firm focused on healthcare transactions. We represent physician groups and practice owners through competitive sale processes — from pre-market preparation through closing. MSO structure, physician alignment, and operational readiness are core elements of how we help clients position for a transaction.
If you’re considering a sale and want to understand how your practice structure will be viewed by buyers, we’re happy to have that conversation.